Find More Contacts for Cambridge Epigenetix
Protected Content
CFO, Financial Officer
Executive Management
1 email found
View contacts for Cambridge Epigenetix to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email info@cegx.co.uk
  • Phone Number +44 1223 800700

Cambridge Epigenetix aims to change the way medicine is practiced by reducing several routine and important diagnostic screening and detection tests for colorectal cancer and other common tumours to a simple blood draw.

CEGX is pioneering the field of clinical epigenetics, and the company’s technology has proven the link between the epigenetic DNA

modification 5-hydroxymethylcytosine (5hmC) and disease. Research has revealed a wide range of diagnostic and prognostic applications for 5hmC, now one of the most important biomarkers in the quest to improve human health.

Spun-out of the University of Cambridge in 2012, CEGX was founded to develop and commercialise the science of world leading researchers Professor Sir Shankar Balasubramanian, co-inventor of Solexa sequencing, and Professor Anjana Rao, who identified the essential role of the TET enzymes and 5hmC in development and disease.

A privately held company headquartered in Cambridge, UK, Cambridge Epigenetix is supported by several high-profile investors: GV (Google Ventures), Sequoia, Syncona, New Science Ventures, Ahren Innovation Capital, DNA Capital and the University of Cambridge.

Lists Featuring This Company

Medical Companies With More Than 50 Employees (Top 10K)
9,856 Number of Organizations • $500.2B Total Funding Amount • 15,525 Number of Investors
Health Care Companies With More Than 10 Employees (Top 10K)
9,807 Number of Organizations • $1.1T Total Funding Amount • 54,646 Number of Investors
Medical Companies With Less Than $10M in Revenue (Top 10K)
9,977 Number of Organizations • $138.3B Total Funding Amount • 19,886 Number of Investors
Health Care Late Stage Companies With More Than 10 Employees
849 Number of Organizations • $106.8B Total Funding Amount • 8,287 Number of Investors

Frequently Asked Questions

Where is Cambridge Epigenetix's headquarters? Cambridge Epigenetix is located in Cambridge, Cambridgeshire, United Kingdom.Who invested in Cambridge Epigenetix? Cambridge Epigenetix has 10 investors including New Science Ventures and Temasek Holdings.How much funding has Cambridge Epigenetix raised to date? Cambridge Epigenetix has raised .When was the last funding round for Cambridge Epigenetix? Cambridge Epigenetix closed its last funding round on Nov 2, 2021 from a Series D round.Who are Cambridge Epigenetix's competitors? Alternatives and possible competitors to Cambridge Epigenetix may include AffimedJoint Academy, and Knopp Biosciences.